Study on the Neurovascular Coupling Function in Patients Undergoing Cardiac Surgery
NCT ID: NCT02977455
Last Updated: 2016-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intraoperative:
1. After admission, the investigators recorded regular vital signs and measured basic cerebral oxygen saturation, then inducted anesthesia.
2. After induction the investigators recorded anesthetic dose, vital signs and measured cerebral blood flow and oxygen saturation changes.
3. Using BIS to monitor we controlled the anesthesia depth at BIS value of 40 to 60.
4. Assuring patient's vital signs to be stable and safe, the investigators gave propofol (3 mg/kg, from Fresenius Kabi) intravenously when BIS was greater than 60 and observed while recorded any changes in BIS value, cerebral blood flow and oxygen saturation.
Postoperative: Patient was transferred to chest surgery ICU and vital signs were recorded.
Clinical data record:
General information: including name, gender, age, height, weight, education, name of disease, surgery method, admission number, ID number, address, contact information and so on;
Preoperative: cardiovascular medicine, vasoactive drugs, lab test results, result reviews, cognition rating and cerebral blood oxygen saturation basic value;
Intraoperative: circulatory parameters, medicine, temperature, BIS value, cerebral blood oxygen saturation and blood flow parameters;
Postoperative: extubation time, time of vasoactive drug administration, cognition rating (postoperative day 3 and day 7), postoperative complications (sudden cardiac death, disturbance of consciousness, pulmonary infection, acute lung injury, acute pulmonary embolism, cerebral infarction and so on);
Postoperative stay in hospital, ICU stay time, hospitalization cost, readmission, mortality (one, three and six months) and so on.
Cognition rating chart: based on "Direction of Chinese Binet Tests (third edition)".
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Will take cardiac surgery and general anesthesia
3. Cognitive status is normal
4. Cardiac function grade Ⅱ-Ⅲ (using the NYHA cardiac function classification)
Exclusion Criteria
2. ASA-V or VI
3. Coagulation disorders,multiple organs dysfunction, endocrine system diseases and severe infectious diseases
4. Patients have been installed pacemakers
5. Suspected or indeed alcohol, drug abuse history
6. Can not cooperate with research, such as the following: language understanding, mental illness, etc.
7. Participated in other clinical trials
8. Perioperative stroke
9. The researchers believe that should not be included in the study
2 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiangya Hospital of Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
304460568
Identifier Type: -
Identifier Source: org_study_id